Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI
Titel:
Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI
Auteur:
Park, Kwonoh Lee, Jae-Lyun Park, Inkeun Park, Seongjoon Ahn, Yongcheol Ahn, Jin-Hee Ahn, Shin Song, Cheryn Hong, Jun Hyuk Kim, Choung-Soo Ahn, Hanjong